Home
|Insights
|"U.S. Healthcare Reform: What's in it for Biosimilars?" European Generics Medicines Association's 8th Annual Symposium on Biosimilars, London

PDF Link

"U.S. Healthcare Reform: What's in it for Biosimilars?" European Generics Medicines Association's 8th Annual Symposium on Biosimilars, London

Speaking Engagement | 09.09.10

Contacts

Keith J. Harrison
Partner
He/Him/His
- Washington, D.C.
  - D | +1.202.624.2560
a2hhcnJpc29uQGNyb3dlbGwuY29t

Insights

Speaking Engagement | 12.11.25

"Ounce of Prevention Session (OOPS) Navigating the Current Compliance, Enforcement, and Oversight Landscape," NAPABA 2025

Speaking Engagement | 12.11.25
"The State of AI Regulation", New York Technology Innovation 2025
Speaking Engagement | 12.10.25
"Antitrust Basics, Updates, and Insights – Navigating Antitrust Issues in Healthcare Markets," Crowell & Moring Webinar.
Speaking Engagement | 12.10.25
"New Cybersecurity Maturity Model Certification Program: Compliance Obligations & Implications for DoD Contractors," BARBRI

View All Insights

Subscribe

to the latest insights from our team